# OnCo record idea-fund-duration-trial-exclusivity (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-fund-duration-trial-exclusivity/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-fund-duration-trial-exclusivity" ;
  schema:name "Extra exclusivity for sponsors who run treatment-duration and de-escalation trials"@en ;
  schema:description "Companies lose money when they prove a shorter course works, so they never test it. Give them a modest reward, such as extra months of exclusivity, when they do."@en ;
  schema:url <https://onco.cc/ideas/idea-fund-duration-trial-exclusivity/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/d41573-022-00030-4> ;
  onco:related <https://onco.cc/ideas/idea-fund-payer-funded-pragmatic-trials/>, <https://onco.cc/ideas/idea-fund-value-based-patent-extension/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/osimertinib/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-incentive-misalignment/>, <https://onco.cc/bottlenecks/b-dose-optimisation/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-upadhaya-nat-rev-drug-discov/> .